The largest database of trusted experimental protocols

Isobutyl methylxantine

Manufactured by Merck Group
Sourced in United States

Isobutyl-methylxantine is a laboratory reagent used as a phosphodiesterase inhibitor. It functions by blocking the enzyme phosphodiesterase, which is responsible for the degradation of cyclic AMP and cyclic GMP. This action can lead to the accumulation of these signaling molecules within cells, potentially affecting various cellular processes.

Automatically generated - may contain errors

2 protocols using isobutyl methylxantine

1

Adipogenic and Osteogenic Differentiation of Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To induce adipogenic differentiation, cells were stained with Oil Red O as previously described.22 (link) 1 × 104 cells cm−2 were cultured in 24-well plates in DMEM high glucose (Sigma, St. Louis, USA) supplemented with 10% FBS, 0.5 mmol l−1 isobutyl-methylxantine, 1 μmol l−1 dexame thasone, 5 μg ml−1 insulin and 150 μmol l−1 indomethacin (Sigma, St. Louis, USA). The cells were cultured, replacing the medium every 3 days. After 21 days of culture, the cells contained lipid droplets; they were fixed in a 10% solution of formaldehyde in aqueous phosphate buffer for about 1 h. Cells were stained with Oil red O solution.
To induce osteogenic differentiation, 1 × 104 cells cm−2 were cultured in 24-well plates in DMEM (Sigma, St. Louis, USA) supplemented with 10% FBS, 10 mmol l−1 β-glycerophosphate (Sigma, St. Louis, USA), 0.2 mmol l−1 ascorbic acid (Sigma, St. Louis, USA), and 100 nmol l−1 dexamethasone (Sigma, St. Louis, USA). Cells were cultured for 25 days, replacing the medium every 3 days. Then the cells were fixed with 10% formalin (Sigma, St. Louis, USA) for 15 min and assessed by Von Kossa staining.23 (link)
+ Open protocol
+ Expand
2

Adipocyte Differentiation and MS-275 Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated at a density of 10 5 cell/ml and differentiated for 4 days in presence of 50M insulin, 100nM dexamethasone, 0.25mM isobutylmethylxantine (Sigma Aldrich), 100nM rosiglitazone (Cayman Chemical). Then medium was refreshed every other day from day 4 to day 10 of differentiation with of 50M insulin, 100nM dexamethasone (Sigma Aldrich), 100nM rosiglitazone (Cayman Chemical). At the end of differentiation cells were treated for 48 hours with DMSO or with 1M MS-275.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!